source
- Vera Therapeutics receives accelerated approval for Trutakna to treat IgA nephropathyVera Therapeutics announced that its fusion protein atacicept, branded as Trutakna, has been granted accelerated approval by the FDA for the treatment of immunoglobulin A nephropathy, a chronic aut…
- CMS launches ACCESS program to reward Medicare digital health solutions that improve outcomesThe Centers for Medicare & Medicaid Services introduced the ACCESS program, a new initiative that invites digital health companies to participate in Medicare. The program ties Medicare payments to…